Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-19-000011

Options or other derivatives

  • Chief Scientific Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2019-01-07 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +100,000 $2.60 $260,000 $2.60 2029-01-06 100,000 100,000 D
Loading xslF345X03/wf-form4_154698234281465.xml…